Taisei Corporation (TYO:1801)
Japan · Delayed Price · Currency is JPY 9,603.00
-9.00 (-0.09%)
Aug 8, 2025, 3:30 PM JST
Regulus Therapeutics Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 178,250 | 57,093 | 68,094 | 103,503 | 135,416 | Upgrade |
Depreciation & Amortization | - | 16,391 | 13,110 | 11,478 | 10,907 | 10,459 | Upgrade |
Loss (Gain) From Sale of Assets | - | 1,422 | 723 | 870 | 973 | 910 | Upgrade |
Loss (Gain) From Sale of Investments | - | -48,590 | -17,870 | -6,027 | -1,610 | -460 | Upgrade |
Loss (Gain) on Equity Investments | - | -10,225 | -4,195 | -2,054 | -893 | -278 | Upgrade |
Other Operating Activities | - | -57,373 | -23,621 | -29,436 | -36,165 | -51,464 | Upgrade |
Change in Accounts Receivable | - | -74,123 | -105,106 | -112,919 | -35,560 | 75,090 | Upgrade |
Change in Inventory | - | -6,937 | -29,170 | -33,967 | 5,893 | -11,013 | Upgrade |
Change in Accounts Payable | - | -27,746 | 84,931 | 52,384 | 46,737 | -133,957 | Upgrade |
Change in Other Net Operating Assets | - | 15,090 | 64,716 | 81,678 | -13,278 | 42,791 | Upgrade |
Operating Cash Flow | - | -13,841 | 40,611 | 30,101 | 80,507 | 67,494 | Upgrade |
Operating Cash Flow Growth | - | - | 34.92% | -62.61% | 19.28% | -12.88% | Upgrade |
Capital Expenditures | - | -31,939 | -122,308 | -16,163 | -13,230 | -12,725 | Upgrade |
Sale of Property, Plant & Equipment | - | 898 | 1,424 | 759 | 263 | 78 | Upgrade |
Cash Acquisitions | - | - | -27,365 | - | - | - | Upgrade |
Divestitures | - | 13,377 | - | - | - | - | Upgrade |
Investment in Securities | - | 28,198 | 9,582 | 1,246 | -24,728 | -6,849 | Upgrade |
Other Investing Activities | - | -3 | -80 | 100 | 15 | 813 | Upgrade |
Investing Cash Flow | - | 10,531 | -138,747 | -14,058 | -37,680 | -18,683 | Upgrade |
Short-Term Debt Issued | - | 3,532 | - | 584 | - | 5,420 | Upgrade |
Long-Term Debt Issued | - | 44,432 | 176,784 | 34,350 | 34,142 | 44,882 | Upgrade |
Total Debt Issued | - | 47,964 | 176,784 | 34,934 | 34,142 | 50,302 | Upgrade |
Short-Term Debt Repaid | - | - | -1,295 | - | -3,462 | - | Upgrade |
Long-Term Debt Repaid | - | -40,500 | -21,133 | -57,557 | -25,432 | -39,548 | Upgrade |
Total Debt Repaid | - | -40,500 | -22,428 | -57,557 | -28,894 | -39,548 | Upgrade |
Net Debt Issued (Repaid) | - | 7,464 | 154,356 | -22,623 | 5,248 | 10,754 | Upgrade |
Repurchase of Common Stock | - | -114,711 | -20,010 | -50,007 | -20,007 | -20,400 | Upgrade |
Dividends Paid | - | -23,877 | -24,384 | -25,722 | -26,598 | -27,296 | Upgrade |
Other Financing Activities | - | -2,645 | -570 | -316 | -506 | -400 | Upgrade |
Financing Cash Flow | - | -133,769 | 109,392 | -98,668 | -41,863 | -37,342 | Upgrade |
Foreign Exchange Rate Adjustments | - | 2,287 | 3,633 | 1,728 | 1,523 | 150 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 1 | 1 | 1 | -2 | -1 | Upgrade |
Net Cash Flow | - | -134,791 | 14,890 | -80,896 | 2,485 | 11,618 | Upgrade |
Free Cash Flow | - | -45,780 | -81,697 | 13,938 | 67,277 | 54,769 | Upgrade |
Free Cash Flow Growth | - | - | - | -79.28% | 22.84% | -15.07% | Upgrade |
Free Cash Flow Margin | - | -2.13% | -4.63% | 0.85% | 4.36% | 3.70% | Upgrade |
Free Cash Flow Per Share | - | -252.44 | -437.66 | 71.35 | 330.45 | 261.94 | Upgrade |
Cash Interest Paid | - | 2,542 | 1,020 | 879 | 915 | 980 | Upgrade |
Cash Income Tax Paid | - | 59,799 | 25,091 | 31,632 | 37,030 | 52,650 | Upgrade |
Levered Free Cash Flow | - | -69,161 | -101,389 | 20,898 | 63,235 | 40,421 | Upgrade |
Unlevered Free Cash Flow | - | -67,554 | -100,714 | 21,436 | 63,804 | 41,027 | Upgrade |
Change in Working Capital | - | -93,716 | 15,371 | -12,824 | 3,792 | -27,089 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.